- Published on
Diagnostic Tests – Anticentromere Antibodies
1. What condition is it associated with?
Anticentromere antibodies are highly specific for CREST syndrome, which represents the limited cutaneous form of systemic sclerosis.
CREST is an acronym for:
By contrast, anti–topoisomerase I (Scl-70) antibodies are associated with diffuse systemic sclerosis, the more severe, systemic form of the disease.
2. When do you answer anticentromere antibodies?
You should select anticentromere antibody testing as the best initial or confirmatory test when a clinical scenario describes:
Exam pearl:
Limited scleroderma / CREST → Anticentromere antibodies
Diffuse systemic sclerosis → Scl-70 antibodies
1. What condition is it associated with?
Anticentromere antibodies are highly specific for CREST syndrome, which represents the limited cutaneous form of systemic sclerosis.
CREST is an acronym for:
- Calcinosis
- Raynaud phenomenon
- Esophageal dysmotility
- Sclerodactyly
- Telangiectasia
By contrast, anti–topoisomerase I (Scl-70) antibodies are associated with diffuse systemic sclerosis, the more severe, systemic form of the disease.
2. When do you answer anticentromere antibodies?
You should select anticentromere antibody testing as the best initial or confirmatory test when a clinical scenario describes:
- A woman aged 30–50 years
- Symptoms suggestive of limited systemic sclerosis (e.g., Raynaud phenomenon, skin tightening of fingers, telangiectasias)
- Positive antinuclear antibody (ANA)
- Often a positive rheumatoid factor
Exam pearl:
Limited scleroderma / CREST → Anticentromere antibodies
Diffuse systemic sclerosis → Scl-70 antibodies
- Published on
Diagnostic Tests – 17-Hydroxyprogesterone Level
1. What is this test?
The 17-hydroxyprogesterone (17-OHP) level is a screening blood test used to diagnose congenital adrenal hyperplasia (CAH), most commonly due to 21-hydroxylase deficiency. In this condition, impaired cortisol synthesis leads to accumulation of 17-hydroxyprogesterone, which is shunted into androgen production.
2. When do you answer it?
You should select a 17-hydroxyprogesterone level when the clinical scenario suggests excess androgen production or impaired adrenal steroid synthesis, including:
In exam settings, these presentations strongly point toward 21-hydroxylase deficiency, making 17-hydroxyprogesterone the best initial diagnostic test.
1. What is this test?
The 17-hydroxyprogesterone (17-OHP) level is a screening blood test used to diagnose congenital adrenal hyperplasia (CAH), most commonly due to 21-hydroxylase deficiency. In this condition, impaired cortisol synthesis leads to accumulation of 17-hydroxyprogesterone, which is shunted into androgen production.
2. When do you answer it?
You should select a 17-hydroxyprogesterone level when the clinical scenario suggests excess androgen production or impaired adrenal steroid synthesis, including:
- Female infant with ambiguous genitalia (simple virilizing form)
- Infant with hyponatremia, hyperkalemia, and hypotension (salt-wasting crisis)
- Young woman with hirsutism, acne, and irregular menses
- Child with precocious puberty
In exam settings, these presentations strongly point toward 21-hydroxylase deficiency, making 17-hydroxyprogesterone the best initial diagnostic test.
- Published on
Diagnostic Tests – Fungal Culture
1. For which clinical scenario(s) is this the best (most accurate) test?
A fungal culture is the most accurate confirmatory test for superficial fungal infections, including:
It allows definitive identification of the fungal organism and is especially useful when the diagnosis is uncertain or treatment has failed.
2. When is this test the best initial step?
Never.
Although fungal culture is highly accurate, it is not the best initial diagnostic test. Superficial fungal infections are primarily diagnosed by:
3. What is the management?
Treatment depends on the location of the fungal infection:
Suspected fungal infection → KOH prep first
Need definitive identification or refractory case → Fungal culture
1. For which clinical scenario(s) is this the best (most accurate) test?
A fungal culture is the most accurate confirmatory test for superficial fungal infections, including:
- Tinea infections (corporis, cruris, pedis)
- Onychomycosis (nail infections)
- Fungal vaginitis
It allows definitive identification of the fungal organism and is especially useful when the diagnosis is uncertain or treatment has failed.
2. When is this test the best initial step?
Never.
Although fungal culture is highly accurate, it is not the best initial diagnostic test. Superficial fungal infections are primarily diagnosed by:
- Clinical appearance
- KOH preparation (to visualize hyphae or yeast)
3. What is the management?
Treatment depends on the location of the fungal infection:
- Require oral antifungals:
- Onychomycosis
- Tinea capitis
- Medications: terbinafine or itraconazole
- Treated with topical antifungals:
- Most other cutaneous fungal infections
- Medications: ketoconazole, clotrimazole, nystatin, ciclopirox
Suspected fungal infection → KOH prep first
Need definitive identification or refractory case → Fungal culture
- Published on
Diagnostic Tests – Excision Skin Biopsy
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
1. For which clinical scenario(s) is this diagnostic tool indicated?
An excision skin biopsy is a diagnostic technique in which the entire skin lesion is removed with full thickness, ideally in one intact specimen. It is indicated when there is high clinical suspicion for malignancy, particularly when accurate assessment of lesion depth, margins, and architecture is required for diagnosis and staging.
2. For which condition is this test always the right answer?
An excision biopsy is always the correct diagnostic test for suspected malignant melanoma. Melanoma requires complete removal of the lesion to allow proper evaluation of Breslow depth, which is critical for staging and prognosis. Partial biopsies (such as shave or punch biopsies) are inadequate because they may prevent accurate staging and risk underestimating tumor depth.
Key exam pearl: If melanoma is suspected, excision biopsy is the answer—always.
- Published on
Diagnostic Tests – Progesterone Challenge Test
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
1. For which clinical scenario(s) is this the best test?
The progesterone challenge test is used in the evaluation of amenorrhea after pregnancy has been excluded with a negative hCG test. It is most appropriate for a woman who has absent menstrual periods and helps determine whether amenorrhea is due to outflow tract obstruction or dysfunction at the level of the hypothalamus or pituitary. The test typically involves administering oral progesterone (about 10 mg daily for 5 days).
2. If bleeding occurs after the challenge, what does it indicate?
If withdrawal bleeding occurs, this indicates that:
- Estrogen levels are adequate to build up the endometrial lining
- The uterus and outflow tract are intact and patent
This finding suggests that the amenorrhea is not due to an anatomic obstruction.
3. What is the next best test if bleeding occurs?
If bleeding occurs, the next step is to evaluate for hypothalamic or pituitary causes of amenorrhea. This is done by checking:
- FSH
- LH
- Prolactin
- TSH
These tests help identify endocrine disorders such as hyperprolactinemia, hypothyroidism, or gonadotropin abnormalities.
4. If there is no bleeding, what is the next best test?
If no withdrawal bleeding occurs, this suggests either insufficient estrogen or an outflow tract obstruction. The next best step is to evaluate the reproductive anatomy, starting with pelvic ultrasound. If ultrasound findings are inconclusive, MRI is used to further assess for structural abnormalities or obstruction of the uterine outflow tract.
- Published on
Diagnostic Tests – Metaiodobenzylguanidine (MIBG) Scan
1. What disease is this test for?
The metaiodobenzylguanidine (MIBG) scan is used to detect pheochromocytoma, particularly when the tumor is occult or not visualized on standard imaging. It is not a screening test; instead, it is used after biochemical confirmation of catecholamine excess (elevated metanephrines, catecholamines, or VMA) when CT or MRI fails to localize the tumor.
2. How is the test done?
MIBG, a compound structurally similar to norepinephrine, is injected intravenously. Because pheochromocytomas arise from adrenergic tissue, they actively take up MIBG. Nuclear imaging is then performed to visualize areas of tracer accumulation, allowing identification of adrenal or extra-adrenal catecholamine-secreting tumors.
3. When do you answer an MIBG scan?
You should select an MIBG scan in a patient who has:
This test is essential because a pheochromocytoma cannot be surgically cured unless it is accurately localized.
1. What disease is this test for?
The metaiodobenzylguanidine (MIBG) scan is used to detect pheochromocytoma, particularly when the tumor is occult or not visualized on standard imaging. It is not a screening test; instead, it is used after biochemical confirmation of catecholamine excess (elevated metanephrines, catecholamines, or VMA) when CT or MRI fails to localize the tumor.
2. How is the test done?
MIBG, a compound structurally similar to norepinephrine, is injected intravenously. Because pheochromocytomas arise from adrenergic tissue, they actively take up MIBG. Nuclear imaging is then performed to visualize areas of tracer accumulation, allowing identification of adrenal or extra-adrenal catecholamine-secreting tumors.
3. When do you answer an MIBG scan?
You should select an MIBG scan in a patient who has:
- Symptoms suggestive of pheochromocytoma (e.g., palpitations, episodic hypertension, intermittent tachycardia, diaphoresis)
- Positive biochemical testing (elevated catecholamines, metanephrines, or VMA)
- Negative or nondiagnostic CT or MRI
This test is essential because a pheochromocytoma cannot be surgically cured unless it is accurately localized.
- Published on
Diagnostic Tests – 5-HIAA (5-Hydroxyindoleacetic Acid)
1. What is this test?
A 24-hour urine 5-HIAA level measures 5-hydroxyindoleacetic acid, the primary end-product of serotonin metabolism. It is the best initial diagnostic test for carcinoid syndrome, reflecting excess serotonin production by neuroendocrine tumors.
2. When do you answer a 5-HIAA level?
You should choose a 5-HIAA test when a patient presents with episodic symptoms suggestive of carcinoid syndrome, including:
The combination of flushing plus diarrhea is particularly high-yield for test questions.
3. What is the most accurate diagnostic test?
The most accurate diagnostic test for carcinoid syndrome is a biopsy with histologic confirmation. While CT and MRI scans can help localize tumors or metastases, they are not as definitive as tissue diagnosis obtained through biopsy.
1. What is this test?
A 24-hour urine 5-HIAA level measures 5-hydroxyindoleacetic acid, the primary end-product of serotonin metabolism. It is the best initial diagnostic test for carcinoid syndrome, reflecting excess serotonin production by neuroendocrine tumors.
2. When do you answer a 5-HIAA level?
You should choose a 5-HIAA test when a patient presents with episodic symptoms suggestive of carcinoid syndrome, including:
- Recurrent watery diarrhea
- Unexplained flushing
- Wheezing or bronchospasm
- Episodic hypotension
The combination of flushing plus diarrhea is particularly high-yield for test questions.
3. What is the most accurate diagnostic test?
The most accurate diagnostic test for carcinoid syndrome is a biopsy with histologic confirmation. While CT and MRI scans can help localize tumors or metastases, they are not as definitive as tissue diagnosis obtained through biopsy.
- Published on
Diagnostic Tests – Fine-Needle Aspiration (FNA) of the Thyroid
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
1. What is this test?
Fine-needle aspiration (FNA) of the thyroid is a minimally invasive procedure in which a thin needle is used to obtain a sample of thyroid cells for cytologic examination. It is the initial diagnostic test of choice for most solitary thyroid nodules, as it helps determine whether a nodule is benign or malignant.
2. When is this the most accurate test?
FNA is the most appropriate and accurate next step when a patient has:
- A palpable solitary thyroid nodule
- Normal thyroid function tests (euthyroid state)
In exam questions, if a euthyroid patient with a thyroid nodule is described and the question asks for the next step in diagnosis, the correct answer is typically fine-needle aspiration.
3. When is this the wrong answer?
FNA is not the correct initial test in patients with a solitary thyroid nodule who are thyrotoxic (suppressed TSH, elevated T3/T4). In this scenario, a thyroid scintigraphy (radioiodine uptake scan) should be performed first to determine whether the nodule is:
- Hyperfunctioning (“hot”) — almost never malignant
- Hypofunctioning (“cold”) — higher risk of malignancy and may then require FNA
- Published on
Diagnostic Tests – Diascopy
1. For which clinical condition(s) is this test commonly used?
Diascopy is a simple bedside test used in dermatology for the initial evaluation of erythematous skin lesions. It helps determine whether skin redness is due to vasodilation or extravasation of red blood cells from damaged blood vessels. The test is performed by pressing a clear glass or plastic slide against the lesion.
2. What do you look for?
During diascopy, you observe whether the lesion blanches (turns white) when pressure is applied:
This distinction is clinically important, as non-blanching lesions often suggest more serious underlying pathology requiring further investigation.
1. For which clinical condition(s) is this test commonly used?
Diascopy is a simple bedside test used in dermatology for the initial evaluation of erythematous skin lesions. It helps determine whether skin redness is due to vasodilation or extravasation of red blood cells from damaged blood vessels. The test is performed by pressing a clear glass or plastic slide against the lesion.
2. What do you look for?
During diascopy, you observe whether the lesion blanches (turns white) when pressure is applied:
- Blanching lesion
→ Indicates vasodilation
→ Common in viral exanthems, drug reactions, and insect bites - Non-blanching lesion
→ Indicates extravasation of erythrocytes due to vascular damage
→ Seen in vasculitic and purpuric conditions
This distinction is clinically important, as non-blanching lesions often suggest more serious underlying pathology requiring further investigation.
- Published on
Diagnostic Tests – Direct Immunofluorescence (DIF) of Skin Biopsy
1. For which clinical condition(s) is this the most accurate test?
Direct immunofluorescence (DIF) is the most accurate diagnostic test for immunologic blistering skin disorders, particularly:
It is also used for other immune-mediated dermatoses where antibody or complement deposition patterns are diagnostic.
2. When is this test the best initial step?
DIF is the best initial diagnostic step when a patient presents with:
The test is performed on a skin biopsy taken from perilesional (normal-appearing) skin, not from the blister itself.
DIF evaluates the presence and pattern of deposition of:
Management depends on the diagnosis confirmed by DIF:
1. For which clinical condition(s) is this the most accurate test?
Direct immunofluorescence (DIF) is the most accurate diagnostic test for immunologic blistering skin disorders, particularly:
- Pemphigus vulgaris
- Bullous pemphigoid
It is also used for other immune-mediated dermatoses where antibody or complement deposition patterns are diagnostic.
2. When is this test the best initial step?
DIF is the best initial diagnostic step when a patient presents with:
- Blistering skin disease
- Suspicion of an autoimmune etiology
- Findings such as fragile bullae, mucosal involvement, or tense blisters
The test is performed on a skin biopsy taken from perilesional (normal-appearing) skin, not from the blister itself.
DIF evaluates the presence and pattern of deposition of:
- IgG
- IgM
- IgA
- C3
- Fibrinogen
Management depends on the diagnosis confirmed by DIF:
- Pemphigus vulgaris
- DIF finding: IgG and C3 between epidermal cells (fish-net pattern)
- Treatment: Systemic corticosteroids ± immunosuppressants
- Bullous pemphigoid
- DIF finding: IgG and C3 at the dermoepidermal junction (linear pattern)
- Treatment: Topical or systemic corticosteroids, depending on severity
